Louis Edward Tamayo

Insider Reports History

Location
New Canaan, CT
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Louis Edward Tamayo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Financial Officer Common Stock 89,665 $890,373 $9.93 04 Feb 2026 Direct
Lexeo Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 226,665 04 Feb 2026 Direct

Insider Reports Filed by Louis Edward Tamayo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 04 Feb 2026 2 $0 4 Chief Financial Officer 06 Feb 2026, 17:00
LXEO Lexeo Therapeutics, Inc. 29 Aug 2025 2 $0 4 Chief Financial Officer 03 Sep 2025, 14:00
LXEO Lexeo Therapeutics, Inc. 15 Aug 2025 0 $0 3 Chief Financial Officer 27 Aug 2025, 18:51